Literature DB >> 8559979

How dangerous is low level radiation?

B L Cohen1.   

Abstract

Problems in the theoretical basis for the linear-no threshold theory of radiation carcinogenesis are reviewed, and it is shown that they very strongly suggest that the theory greatly overestimates the risk of low level radiation. A direct test of the theory, based on the radon-lung cancer relationship is described; it strongly reinforces that conclusion. However, it is shown that even if the linear-no threshold theory is valid, the public's fear of low level radiation, at least in some contexts, is grossly exaggerated.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8559979     DOI: 10.1111/j.1539-6924.1995.tb01336.x

Source DB:  PubMed          Journal:  Risk Anal        ISSN: 0272-4332            Impact factor:   4.000


  6 in total

1.  On "phantom risks" associated with diagnostic ionizing radiation: evidence in support of revising radiography standards and regulations in chiropractic.

Authors:  Paul A Oakley; Donald D Harrison; Deed E Harrison; Jason W Haas
Journal:  J Can Chiropr Assoc       Date:  2005-12

2.  A rebuttal to chiropractic radiologists' view of the 50-year-old, linear-no-threshold radiation risk model.

Authors:  Paul A Oakley; Donald D Harrison; Deed E Harrison; Jason W Haas
Journal:  J Can Chiropr Assoc       Date:  2006-09

Review 3.  Anti-inflammatory effects of low-dose radiotherapy. Indications, dose, and radiobiological mechanisms involved.

Authors:  M Arenas; S Sabater; V Hernández; A Rovirosa; P C Lara; A Biete; J Panés
Journal:  Strahlenther Onkol       Date:  2012-08-22       Impact factor: 3.621

Review 4.  Lung cancer: epidemiology, etiology, and prevention.

Authors:  Charles S Dela Cruz; Lynn T Tanoue; Richard A Matthay
Journal:  Clin Chest Med       Date:  2011-12       Impact factor: 2.878

5.  Is bad luck the main cause of cancer?

Authors:  C R Weinberg; D Zaykin
Journal:  J Natl Cancer Inst       Date:  2015-05-08       Impact factor: 13.506

6.  Molecular docking studies of Traditional Chinese Medicinal compounds against known protein targets to treat non-small cell lung carcinomas.

Authors:  Guo-Fang Zhao; Zuo-An Huang; Xue-Kui Du; Ming-Lei Yang; Dan-Dan Huang; Shun Zhang
Journal:  Mol Med Rep       Date:  2016-05-27       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.